{"organizations": [], "uuid": "2dcc6e74e66cdc62ac3badfaf91352113d36ae2f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/britain-press-ft/press-digest-financial-times-feb-9-idUSL4N1PZ07Y", "country": "US", "domain_rank": 408, "title": "PRESS DIGEST- Financial Times - Feb 9", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-09T02:50:00.000+02:00", "replies_count": 0, "uuid": "2dcc6e74e66cdc62ac3badfaf91352113d36ae2f"}, "author": "", "url": "https://www.reuters.com/article/britain-press-ft/press-digest-financial-times-feb-9-idUSL4N1PZ07Y", "ord_in_thread": 0, "title": "PRESS DIGEST- Financial Times - Feb 9", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "uk", "sentiment": "none"}, {"name": "israel", "sentiment": "none"}, {"name": "washington", "sentiment": "none"}], "organizations": [{"name": "financial times", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "hiscox", "sentiment": "none"}, {"name": "facebook inc", "sentiment": "none"}, {"name": "google", "sentiment": "none"}, {"name": "alphabet inc", "sentiment": "none"}, {"name": "hiscox ltd", "sentiment": "none"}, {"name": "teva", "sentiment": "none"}, {"name": "twitter inc", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 9 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.\nHeadlines\nMPs attack U.S. technology companies over fake news on.ft.com/2BPb7Ht\nTeva warns on revenue amid tough U.S. drug pricing on.ft.com/2BPmO0V\nUK insurance company Hiscox accused of data protection breach on.ft.com/2BNppbs\nOverview\nBritish MPs on Thursday attacked Facebook Inc, Alphabet Inc’s Google and Twitter Inc in Washington over what the parliamentarians regard as failures by the tech giants to fully investigate Russian interference in the Brexit referendum and 2017 election.\nShares in Israel’s Teva Pharmaceutical Industries Ltd fell sharply after it forecast a drop in revenue in 2018 in spite of aggressive cost-cutting that will lose as many as 14,000 workers by the end of 2019.\nInsurance company Hiscox Ltd went on trial on Thursday, accused of breaching data protection laws in its handling of a customer’s claim about the loss of a 30,000-pound ($41,778.00) Swiss luxury watch. ($1 = 0.7181 pounds) (Compiled by Bengaluru newsroom; Editing by Sandra Maler)\n ", "external_links": [], "published": "2018-02-09T02:50:00.000+02:00", "crawled": "2018-02-09T03:08:57.003+02:00", "highlightTitle": ""}